Mohamad I - Search Results

1

Induction Methotrexate, Cisplatin, and 5-Fluorouracil Versus Cisplatin and 5-Fluorouracil Followed by Radiotherapy in Pediatric Nasopharyngeal Carcinoma: A Retrospective Analysis in a Tertiary Cancer Center.

Al Mousa A, Abu-Hijlih R, Salem A, Sultan I, Mula-Hussain L, Ismael T, Mohamad I. Al Mousa A, et al. Among authors: mohamad i. J Pediatr Hematol Oncol. 2017 Nov;39(8):e437-e442. doi: 10.1097/MPH.0000000000000933. J Pediatr Hematol Oncol. 2017. PMID: 28816803

2

The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care.

Salem A, Hashem SA, Al-Rashdan A, Ezam N, Nour A, Alsharbaji A, Sughayer M, Mohamad I, Elyan M, Addas A, Al-Hussaini M, Almousa A. Salem A, et al. Among authors: mohamad i. Hematol Oncol Stem Cell Ther. 2011;4(3):116-20. doi: 10.5144/1658-3876.2011.116. Hematol Oncol Stem Cell Ther. 2011. PMID: 21982884 Free article.

3

Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme.

Hashem SA, Salem A, Al-Rashdan A, Ezam N, Nour A, Alsharbaji A, Rejeeth C, Mohamad I, Sughayer M, Elyan M, Al-Hussaini M, Addasi A, Almousa A. Hashem SA, et al. Among authors: mohamad i. J Med Imaging Radiat Oncol. 2012 Apr;56(2):204-10. doi: 10.1111/j.1754-9485.2011.02325.x. J Med Imaging Radiat Oncol. 2012. PMID: 22498195

4

Combined photon-electron beams in the treatment of the supraclavicular lymph nodes in breast cancer: A novel technique that achieves adequate coverage while reducing lung dose.

Salem A, Mohamad I, Dayyat A, Kanaa'n H, Sarhan N, Roujob I, Salem AF, Afifi S, Jaradat I, Mubiden R, Almousa A. Salem A, et al. Among authors: mohamad i. Med Dosim. 2015 Autumn;40(3):210-7. doi: 10.1016/j.meddos.2014.12.001. Epub 2015 Jan 13. Med Dosim. 2015. PMID: 25595492

5

Peer-assisted Learning: Intensity-modulated Radiotherapy Transition in Developing Countries.

Mohamad I, Salem A, Abu Hejleh T, Wadi-Ramahi S, Qandeel M, El Khatib S, Asha W, Mhied S, Al Saraireh O, Al-Gargaz W, Abdulelah H, Hosni A, Al Mousa A. Mohamad I, et al. Clin Oncol (R Coll Radiol). 2017 Oct;29(10):689-695. doi: 10.1016/j.clon.2017.06.002. Epub 2017 Jun 21. Clin Oncol (R Coll Radiol). 2017. PMID: 28647432

6

Adaptive radiotherapy in patients receiving neoadjuvant radiation for soft tissue sarcoma.

Abu-Hijlih R, Mheid S, Abuhijla F, Asha W, Mohamad I, Alrashdan A, Alheet S, Kana'an H, Abd Al-Raheem M, Almousa A. Abu-Hijlih R, et al. Among authors: mohamad i. Rep Pract Oncol Radiother. 2019 May-Jun;24(3):263-268. doi: 10.1016/j.rpor.2019.02.007. Epub 2019 Mar 18. Rep Pract Oncol Radiother. 2019. PMID: 30936782 Free PMC article.

7

Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan.

Khader JK, Al-Mousa AM, Mohamad IA, Abuhijlih RA, Al-Khatib SA, Alnsour AZ, Asha WA, Ramahi SW, Hosni AA, Abuhijla FJ. Khader JK, et al. Radiat Oncol J. 2019 Mar;37(1):60-65. doi: 10.3857/roj.2019.00080. Epub 2019 Mar 31. Radiat Oncol J. 2019. PMID: 30947482 Free PMC article.

8

Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.

Shamseddine A, Zeidan YH, El Husseini Z, Kreidieh M, Al Darazi M, Turfa R, Kattan J, Khalifeh I, Mukherji D, Temraz S, Alqasem K, Amarin R, Al Awabdeh T, Deeba S, Jamali F, Mohamad I, Elkhaldi M, Daoud F, Al Masri M, Dabous A, Hushki A, Jaber O, Charafeddine M, Geara F. Shamseddine A, et al. Among authors: mohamad i. Radiat Oncol. 2020 Oct 7;15(1):233. doi: 10.1186/s13014-020-01673-6. Radiat Oncol. 2020. PMID: 33028346 Free PMC article. Clinical Trial.

9

Moving Experience from North America to Developing Country to Approach a Desired Level of Quality Assurance in Head and Neck Radiation Therapy.

Mohamad I, Hosni A, Abu-Hijlih R, Al Mousa A, Al-Rimawi D, Abuhijla F. Mohamad I, et al. J Cancer Educ. 2022 Aug;37(4):1036-1042. doi: 10.1007/s13187-020-01917-9. Epub 2020 Oct 31. J Cancer Educ. 2022. PMID: 33128212

10

The influence of 68Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapy.

Al-Ibraheem A, Abuhijla F, Salah S, Shahait M, Khader J, Mohamad I, Al-Rasheed U, Pomykala KL, Herrmann K, Abu-Hijlih R. Al-Ibraheem A, et al. Among authors: mohamad i. Nucl Med Commun. 2021 Jul 1;42(7):811-817. doi: 10.1097/MNM.0000000000001394. Nucl Med Commun. 2021. PMID: 33660693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters